TrialPloS one2022

Effect of empagliflozin on coronary microvascular function in patients with type 2 diabetes mellitus-A randomized, placebo-controlled cross-over study.

Hannah Elena Suhrs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.